| Financial Year |
March 31 2023 |
| Monetary Funds |
408,237,995.99 |
| Held-for-trading Financial Assets |
101,933,166.49 |
| Notes Receivable |
-- |
| Accounts Receivable |
222,200,502.23 |
| Advances to Suppliers |
10,659,210.25 |
| Other Receivables |
88,530,546.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,636,984.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,707,552.41 |
| Total Current Assets |
858,216,658.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,203,688.82 |
| Investment Properties |
-- |
| Fixed Assetes |
20,958,534.38 |
| Under-construction Projects |
152,169.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,077,466.44 |
| R&D expenses |
429,149.21 |
| Goodwill |
35,935,384.85 |
| Long-Term Deferred and Prepaid Expenses |
6,968,814.48 |
| Deferred Income Tax Assets |
12,062,961.56 |
| Other Non-Current Assets |
1,731,853.23 |
| Sub-Total of Non-Current Assets |
205,228,342.84 |
| Total Assets |
1,063,445,001.56 |
| Short-Term Loans |
10,010,388.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
70,150,748.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,953,923.61 |
| Taxes Payable |
13,086,544.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,327,098.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,972,782.95 |
| Other Current Liabilities |
389,839.27 |
| Sub-Total of Current Liabilities |
238,063,213.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,167,461.74 |
| Deferred Income Tax Liabilities |
1,138,673.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,845,189.56 |
| Total Liabilities |
260,908,403.18 |
| Paid-In Capital(Or Share Stock) |
633,333,422.00 |
| Capital Surplus |
979,189,622.03 |
| Surplus Reserve |
23,961,433.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-937,426,357.19 |
| Minority Stockholder's Interest |
102,420,468.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
700,116,130.04 |
| Owner's Equity（Stockholder's Equity） |
802,536,598.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,063,445,001.56 |
